HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient CareAlessandra Fabi, Marcella Mottolese, Anna Di Benedetto et al.|Clinical Cancer Research|2011Cited by 98
Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based ChemotherapyClaudio Botti, Marcella Mottolese, Pier Giorgio Natali et al.|Clinical Cancer Research|2004Cited by 40
Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activityNadia Zaffaroni, Maria Grazia Daidone, Chiara Della Porta et al.|The Journal of Pathology|2002Cited by 35
Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapyMarcella Mottolese, Claudio Botti, Maria Benevolo et al.|Journal of Cancer Research and Clinical Oncology|2000Cited by 21
Data from HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient CareAlessandra Fabi, Marcella Mottolese, Anna Di Benedetto et al.|Unknown|2023Cited by 0